Commentary By: Cara Litvin PGY-3
The FDA recently informed physicians of a report issued by GlaxoSmithKline acknowledging that Avandia (rosiglitazone) has been linked to increased fractures in females (1). The report stems from a review of the safety data from ADOPT (A …
Due to vital conflicting commitments (vacation), Clinical Correlations will be closed until March 6th when we will resume posting new content. This is the perfect opportunity to catch up on our previous content and to think about what …
Commentary By: Sandeep Mangalmurti MD, JD PGY-1
Commentary By: Cara Litvin PGY-3